214 related articles for article (PubMed ID: 9234319)
1. Evaluation of a direct method for technetium labeling intact and F(ab')2 1A3, an anticolorectal monoclonal antibody.
Schwarz SW; Connett JM; Anderson CJ; Rocque PA; Philpott GW; Guo LW; Welch MJ
Nucl Med Biol; 1994 May; 21(4):619-26. PubMed ID: 9234319
[TBL] [Abstract][Full Text] [Related]
2. Preparation of a pure 99mTc-F(ab')2 radioimmunoconjugate by direct labeling methods.
Griffiths GL; Goldenberg DM; Jones AL; Hansen HJ
Nucl Med Biol; 1994 May; 21(4):649-55. PubMed ID: 9234323
[TBL] [Abstract][Full Text] [Related]
3. Preparation, biodistribution and dosimetry of copper-64-labeled anti-colorectal carcinoma monoclonal antibody fragments 1A3-F(ab')2.
Anderson CJ; Schwarz SW; Connett JM; Cutler PD; Guo LW; Germain CJ; Philpott GW; Zinn KR; Greiner DP; Meares CF
J Nucl Med; 1995 May; 36(5):850-8. PubMed ID: 7738663
[TBL] [Abstract][Full Text] [Related]
4. Copper-64-labeled antibodies for PET imaging.
Anderson CJ; Connett JM; Schwarz SW; Rocque PA; Guo LW; Philpott GW; Zinn KR; Meares CF; Welch MJ
J Nucl Med; 1992 Sep; 33(9):1685-91. PubMed ID: 1517844
[TBL] [Abstract][Full Text] [Related]
5. Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism.
Rogers BE; Anderson CJ; Connett JM; Guo LW; Edwards WB; Sherman EL; Zinn KR; Welch MJ
Bioconjug Chem; 1996; 7(4):511-22. PubMed ID: 8853465
[TBL] [Abstract][Full Text] [Related]
6. Identification of metabolites of 111In-diethylenetriaminepentaacetic acid-monoclonal antibodies and antibody fragments in vivo.
Rogers BE; Franano FN; Duncan JR; Edwards WB; Anderson CJ; Connett JM; Welch MJ
Cancer Res; 1995 Dec; 55(23 Suppl):5714s-5720s. PubMed ID: 7493333
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody Fab' fragment cross-linking using equilibrium transfer alkylation reagents. A strategy for site-specific conjugation of diagnostic and therapeutic agents with F(ab')2 fragments.
Wilbur DS; Stray JE; Hamlin DK; Curtis DK; Vessella RL
Bioconjug Chem; 1994; 5(3):220-35. PubMed ID: 7918742
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor.
Burvenich IJ; Schoonooghe S; Blanckaert P; Bacher K; Vervoort L; Coene E; Mertens N; De Vos F; Slegers G
Nucl Med Biol; 2007 Apr; 34(3):257-65. PubMed ID: 17383575
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution and histological localization of anti-human colon cancer monoclonal antibody (MAb) 1A3: the influence of administered MAb dose on tumor uptake.
Fenwick JR; Philpott GW; Connett JM
Int J Cancer; 1989 Dec; 44(6):1017-27. PubMed ID: 2691405
[TBL] [Abstract][Full Text] [Related]
11. A cross-linked monoclonal antibody fragment for improved tumor targeting.
Stalteri MA; Mather SJ
Bioconjug Chem; 1995; 6(2):179-86. PubMed ID: 7599261
[TBL] [Abstract][Full Text] [Related]
12. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancer.
de Bree R; Roos JC; Quak JJ; den Hollander W; Wilhelm AJ; van Lingen A; Snow GB; Dongen GA
Clin Cancer Res; 1995 Mar; 1(3):277-86. PubMed ID: 9815983
[TBL] [Abstract][Full Text] [Related]
14. Targeting of liver metastases of colorectal cancer with IgG, F(ab')2, and Fab' anti-carcinoembryonic antigen antibodies labeled with 99mTc: the role of metabolism and kinetics.
Behr T; Becker W; Hannappel E; Goldenberg DM; Wolf F
Cancer Res; 1995 Dec; 55(23 Suppl):5777s-5785s. PubMed ID: 7493346
[TBL] [Abstract][Full Text] [Related]
15. Catabolism of radioiodinated murine monoclonal antibody F(ab')2 fragment labeled using N-succinimidyl 3-iodobenzoate and Iodogen methods.
Garg PK; Alston KL; Zalutsky MR
Bioconjug Chem; 1995; 6(4):493-501. PubMed ID: 7578370
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization, and in vivo biodistribution properties of synthetically cross-linked multivalent antitumor antibody fragments.
Schott ME; Frazier KA; Pollock DK; Verbanac KM
Bioconjug Chem; 1993; 4(2):153-65. PubMed ID: 7873647
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic mice.
Massuger LF; Boerman OC; Corstens FH; Verheijen RH; Claessens RA; Poels LG; van den Broek WJ; Kenemans P
Anticancer Res; 1991; 11(6):2051-7. PubMed ID: 1776839
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of 99mTc-metallothionein-B72.3 and its F(ab')2 fragment.
Brown BA; Dearborn CB; Drozynski CA; Sands H
Cancer Res; 1990 Feb; 50(3 Suppl):835s-839s. PubMed ID: 2297730
[TBL] [Abstract][Full Text] [Related]
19. Conjugation of monoclonal antibodies with TETA using activated esters: biological comparison of 64Cu-TETA-1A3 with 64Cu-BAT-2IT-1A3.
Lewis MR; Boswell CA; Laforest R; Buettner TL; Ye D; Connett JM; Anderson CJ
Cancer Biother Radiopharm; 2001 Dec; 16(6):483-94. PubMed ID: 11789025
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.
Molthoff CF; Pinedo HM; Schlüper HM; Nijman HW; Boven E
Br J Cancer; 1992 May; 65(5):677-83. PubMed ID: 1586596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
